This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Web of Science (1) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bergman, S. Articles by Melvin, W. S. Search for Related Content PubMed PubMed Citation Articles by Bergman, S. Articles by Melvin, W. S. Pubmed/NCBI databases Medline Plus Health Information GERD Social Bookmarking                         What's this?

Endolumenal Fundoplication With EsophyX: The Initial North American Experience

Department of Surgery, Center for Minimally Invasive Surgery, The Ohio State University, Columbus, Ohio

Dean J. Mikami, MD

Department of Surgery, Center for Minimally Invasive Surgery, The Ohio State University, Columbus, Ohio

Jeffrey W. Hazey, MD

Department of Surgery, Center for Minimally Invasive Surgery, The Ohio State University, Columbus, Ohio

Jason C. Roland, MD

Department of Surgery, Center for Minimally Invasive Surgery, The Ohio State University, Columbus, Ohio

Rebecca Dettorre, BA

Department of Surgery, Center for Minimally Invasive Surgery, The Ohio State University, Columbus, Ohio

W. Scott Melvin, MD

Department of Surgery, Center for Minimally Invasive Surgery, The Ohio State University, Columbus, Ohio, scott.melvin{at}osumc.edu

EsophyX is a novel endolumenal therapeutic option for the treatment of gastroesophageal reflux disease (GERD). The device is passed into the stomach, where it deploys a series of full-thickness fasteners to create a neogastroesophageal valve. The objective of this study was to demonstrate the safety and characterize the effectiveness of this approach in the initial North American experience. This is a retrospective study of consecutive patients with GERD who had undergone endolumenal fundoplication with the EsophyX device. At follow-up, proton pump inhibitor usage was elicited and 2 validated questionnaires were administered measuring GERD health—related quality of life (range 0-50) and symptom severity (range 0-72). In limited preliminary evaluation, the initial North American experience with endolumenal fundoplication using the EsophyX device is that it appears to be safe and provides moderate effectiveness in treating the symptoms of GERD. Further studies comparing this technique with conventional medical and surgical therapies are necessary.

Key Words: endolumenal fundoplication • GERD • EsophyX

Surgical Innovation, Vol. 15, No. 3, 166-170 (2008)
DOI: 10.1177/1553350608321588


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?